Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
27.00
-0.15 (-0.55%)
Nov 26, 2025, 4:00 PM EST - Market closed
KMTS Stock Forecast
Stock Price Forecast
The 6 analysts that cover KMTS stock have a consensus rating of "Buy" and an average price target of $27.67, which forecasts a 2.48% increase in the stock price over the next year. The lowest target is $23 and the highest is $32.
Price Target: $27.67 (+2.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KMTS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +18.52% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | n/a | Jul 17, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $24 → $23 | Hold | Maintains | $24 → $23 | -14.81% | Apr 16, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $29 | Buy | Initiates | $29 | +7.41% | Mar 31, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $28 | Buy | Initiates | $28 | +3.70% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
89.86M
from 59.82M
Increased by 50.23%
Revenue Next Year
89.87M
from 89.86M
Increased by 0.01%
EPS This Year
-2.23
from -5.13
EPS Next Year
-2.30
from -2.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2026 | 2027 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 93.0M | 93.0M | ||||
| Avg | 89.9M | 89.9M | ||||
| Low | 86.1M | 86.1M |
Revenue Growth
| Revenue Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 55.5% | 3.5% | ||||
| Avg | 50.2% | 0.0% | ||||
| Low | 43.9% | -4.2% |
EPS Forecast
| EPS | 2026 | 2026 | 2027 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.26 | -2.26 | |||
| Avg | -2.23 | -2.30 | |||
| Low | -2.21 | -2.37 |
EPS Growth
| EPS Growth | 2026 | 2026 | 2027 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.